Search research articles
Contact Us
Filters
Showing results (201-210 of 268) with videos related to
Page
of 27
Sort By:
British Journal of Cancer
|
November 24, 2004
Clinical anticancer drug development: targeting the cyclin-dependent kinases
C Benson, S Kaye, P Workman, et al.
Psychological Medicine
|
September 9, 2016
A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset
A Sibelli, T Chalder, H Everitt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 1990
Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508)
T S Maughan, H F Newman, N M Bleehen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1984
A phase I study of the combination of benznidazole and CCNU in man
J T Roberts, N M Bleehen, F Y Lee, et al.
Journal of the National Cancer Institute
|
November 24, 1999
DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90
L R Kelland, S Y Sharp, P M Rogers, et al.
Journal of the National Cancer Institute
|
August 5, 1999
Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
K A Gelmon, E A Eisenhauer, A L Harris, et al.
British Journal of Cancer
|
September 29, 2004
Characterisation of molecular events following cisplatin treatment of two curable ovarian cancer models: contrasting role for p53 induction and apoptosis in vivo
P A Clarke, K E Pestell, F Di Stefano, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2009
From darkness to light with biomarkers in early clinical trials of cancer drugs
C P Carden, U Banerji, S B Kaye, et al.
European Journal of Cancer
|
October 1, 1979
The pharmacokinetics of misonidazole in the dog
R A White, P Workman, L S Freedman, et al.
American Journal of Obstetrics and Gynecology
|
October 1, 1983
Coagulopathy and induced abortion methods: rates and relative risks
M E Kafrissen, M W Barke, P Workman, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 268) with videos related to
Sort By:
Page
of 27
British Journal of Cancer
|
November 24, 2004
Clinical anticancer drug development: targeting the cyclin-dependent kinases
C Benson, S Kaye, P Workman, et al.
Psychological Medicine
|
September 9, 2016
A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset
A Sibelli, T Chalder, H Everitt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 1990
Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508)
T S Maughan, H F Newman, N M Bleehen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1984
A phase I study of the combination of benznidazole and CCNU in man
J T Roberts, N M Bleehen, F Y Lee, et al.
Journal of the National Cancer Institute
|
November 24, 1999
DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90
L R Kelland, S Y Sharp, P M Rogers, et al.
Journal of the National Cancer Institute
|
August 5, 1999
Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
K A Gelmon, E A Eisenhauer, A L Harris, et al.
British Journal of Cancer
|
September 29, 2004
Characterisation of molecular events following cisplatin treatment of two curable ovarian cancer models: contrasting role for p53 induction and apoptosis in vivo
P A Clarke, K E Pestell, F Di Stefano, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2009
From darkness to light with biomarkers in early clinical trials of cancer drugs
C P Carden, U Banerji, S B Kaye, et al.
European Journal of Cancer
|
October 1, 1979
The pharmacokinetics of misonidazole in the dog
R A White, P Workman, L S Freedman, et al.
American Journal of Obstetrics and Gynecology
|
October 1, 1983
Coagulopathy and induced abortion methods: rates and relative risks
M E Kafrissen, M W Barke, P Workman, et al.
Page
of 27